Stem cells as today’s treatment and future potential
Early insights. Smarter decisions.
Cellaviva’s newborn and early childhood genetic screening analyzes genetic variations linked to a wide range of inherited conditions, many serious, but often treatable if detected early.
Think ahead. Act now!
A valuable complement to national screening
In Sweden, all newborns are screened for around 25 conditions via the national PKU program, a vital part of child healthcare. However, not all treatable conditions are included.
Cellaviva’s screening covers many additional diseases, offering a broader picture of your child’s genetic health. Some conditions progress rapidly, often without early warning signs, but can be managed effectively if detected early.
Having this knowledge helps you make choices that truly matter from day one.
Why early knowledge matters
Detects genetic changes associated with over 100 conditions
Focuses on disorders that can be treated or managed with early intervention
Enables preventive actions before symptoms develop
Provides peace of mind by helping parents make informed health decisions
Many of these conditions show no obvious symptoms initially. Once symptoms appear, damage may already have occurred.
Early testing can be crucial.
What the test covers
Analyzes 142 genes linked to over 100 autosomal recessive, dominant, and X-linked disorders, including:
Disorders affecting blood
Disorders affecting the hearing
Inherited metabolic disorders
*Our panel is based on international guidelines for expanded newborn screening.
Who, when and how?
Testing can be performed anytime from 24 hours after birth up to about 2 years of age. The earlier the test is done, the greater the chance to intervene before symptoms start.
Order the test online and collect a simple, painless cheek swab from your child. Then send the sample back in the prepaid package.
All analyses are performed in accredited laboratories, and you’ll receive the results within 2–3 weeks, complete with clear interpretations and guidance for any necessary follow-up.
The screening is ideal for:
Healthy children without known risk factors
Children with unclear symptoms or family history
Parents seeking a broader understanding of their child’s genetic health
Give your child the best start in life
Cellaviva’s screening detects treatable genetic conditions before symptoms appear and complements national newborn programs. The simple, non-invasive test can be done at home, with fast results and expert interpretation from accredited laboratories. All based on internationally recommended standards.